Share on

Latin America Clinical Trials Market Analysis – Segmented By Phase, Design, Indications, By Country (Mexico, Brazil, Chile, Peru, Argentina and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast | 2022 to 2027

Published: March, 2023
ID: 1574
Pages: 145
Formats: report pdf report excel report power bi report ppt

As per our report, the size of the Latin American Clinical Trials Market has been estimated at USD 1.86 Billion in 2022 and is projected to reach USD 2.76 Billion by 2027 at a CAGR of 8.20% from 2022 to 2027

Complexities and volumes of data are constantly increasing in clinical trials. As the cost of development break records and patent cliffs approach, there is an urgent need for pharmaceutical companies to raise R&D efforts. Cloud and analytics convergence is omnipresent, and systematic improvements are being made in the clinical trial phase by digital technologies. Healthcare models are witnessing tectonic shifts and seeing a large inflow of new models of clinical trials that are structured, standardized, and foster patient interest. Drug companies are pushing the boundaries of R&D initiatives to improvise their models of clinical trials that will help them cope with ever-increasing development costs. For pharmaceutical and medical device firms, speedier clinical trials are crucial as they are time and capital intensive.


One of the critical factors that can be related to the growth of clinical research in Latin America is their ability to meet the requirements for subject enrolment, particularly as the need for more subjects and greater diversity of patients is increasing. In addition, retention rates are generally twice in Latin America than in Western Europe, and significantly higher than in the United States and Canada. The key drivers of the clinical trial industry in LATAM usually involve rising disease prevalence, high pharmaceutical industry R&D expenditure, and growth in new treatments such as personalized medicine that supports market growth.

Regulatory systems, however, continue to evolve, and differences between different populations of patients pose ethical problems. Last but not least, there is a need to address substantial variations in regional Spanish and cultural differences among ethnic minority communities, particularly in the preparation of patient services. Some groups of patients may have reduced readability and low economic status. Specific measures need to be taken in such situations to ensure patient rights are protected.

This report on Europe Clinical Trails Market has been segmented into the following categories:

  • By Phase – Phase I, Phase II and Phase III
  • By Design - Interventional trials, Observational trials, Expanded Access trials
  • By Indications – Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose & Ophthalmology  
  • By Country – Mexico, Brazil, Chile, Peru, Argentina and Rest of Latin America

Geographically, the Clinical Trials market in the Latin America region is proceeding with a high CAGR. Emerging market destinations in Latin America are attractive because of the opportunity to collect data from patients with diverse ethnic backgrounds, as well as the availability of qualified investigators, all without the competition or cost they face in more developed nations.

In Brazil, the new clinical studies lift up safety concerns about coronavirus patients that they are taking a high dose of chloroquine drug of Malaria. Brazil’s Techtrials Partnered with TriNetX healthcare organization which have 64 million patients database over the country. It covers 90% of the Brazilian population having various diseases, and it is beneficial for the institutes to take clinical trials on various diseases by knowing the availability of participants. This is the major factor responsible for the growth of the clinical trials market in Brazil. The data of patients available gives the current idea about active corona patients to treat them wisely by focusing on the research. The going on research and development to find this vaccine will give a chance to Brazil clinical trial market to set their position worldwide. 

Major companies operating in the Latin America Clinical Trails Market profiled in this report are Chiltern, Omnicare, PPD, Parexel, Kendle, Quintles, ICON Plc, and Charles River.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]